Part 2/8:
President Trump's approach involves initially imposing low tariffs to allow pharmaceutical companies time to adjust, followed by substantial increases. "Pharmaceuticals will be tariffed probably at the end of the month," he stated, adding that companies could either absorb the costs or relocate manufacturing to the U.S. to avoid tariffs. This strategy aims to incentivize pharmaceutical manufacturing to return to America, aligning with the administration's "America First" policy.